Embla Medical hf (OCSE:EMBLA)
kr 29.8 -0.3 (-1.03%) Market Cap: 12.72 Bil Enterprise Value: 16.05 Bil PE Ratio: 30.97 PB Ratio: 2.45 GF Score: 77/100

Q3 2020 Ossur hf Earnings Call Transcript

Oct 27, 2020 / 08:00AM GMT
Release Date Price: kr42 (-2.33%)
Operator

Welcome to the Ãssur's Q3 Results 2020. (Operator Instructions)

I'll now hand the floor to our speakers. Please begin your meeting.

Jón Sigurdsson;ssur hf.;CEO;President
Ã

&

Yes, thank you. And I would like to welcome you to the Ãssur investor conference call where we will cover the results for the third quarter of 2020. My name is Jón Sigurdsson, and I'm the President and CEO. And with me here today is Sveinn Sölvason, our CFO. We will begin by going through the highlights for the quarter and financial results, after which a question-and-answer session will follow.

Sales are gradually recovering in all major markets, and we have begun to realize a pent-up demand in some markets in APAC and EMEA, even though the outlook regarding the COVID-19 remains quite uncertain. Sales in the third quarter of 2020 amounted to $172 million, which corresponds to about 5% organic decline. Sales in the first 9 months of the year declined by 13% organic. Sales in September were at 90% to 100% of prior

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot